We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
–
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.28M
2
ADP icon
Automatic Data Processing
ADP
+$2.29M
3
AMZN icon
Amazon
AMZN
+$1.57M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.47M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$1.22M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCR
26
DELISTED
CR Bard Inc.
BCR
$2.88M 0.79%
9,100
-100
-1% -$29.7K
ADP icon
27
Automatic Data Processing
ADP
$100B
$2.84M 0.78%
27,738
+22,574
+437% +$2.29M
GOOG icon
28
Alphabet (Google) Class C
GOOG
$3.9T
$2.82M 0.77%
62,480
+880
+1% +$40.3K
CVX icon
29
Chevron
CVX
$388B
$2.78M 0.76%
26,613
+607
+2% +$64.3K
GE icon
30
GE Aerospace
GE
$367B
$2.61M 0.72%
20,186
+13
+0.1% +$1.78K
JNJ icon
31
Johnson & Johnson
JNJ
$634B
$2.46M 0.68%
18,644
+328
+2% +$41.8K
GILD icon
32
Gilead Sciences
GILD
$161B
$2.43M 0.67%
34,425
-855
-2% -$56.9K
CL icon
33
Colgate-Palmolive
CL
$72.6B
$2.42M 0.66%
32,645
+1,037
+3% +$77K
T icon
34
AT&T
T
$165B
$2.4M 0.66%
84,281
-5,640
-6% -$166K
MMP
35
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.32M 0.64%
32,120
+11,070
+53% +$813K
CSX icon
36
CSX Corp
CSX
$98.6B
$2.25M 0.62%
124,161
+30,819
+33% +$528K
VZ icon
37
Verizon
VZ
$194B
$2.21M 0.61%
49,276
+2,572
+6% +$120K
JPM icon
38
JPMorgan Chase
JPM
$939B
$2.17M 0.6%
23,785
+2,425
+11% +$209K
INTC icon
39
Intel
INTC
$464B
$2.1M 0.58%
61,787
+19,499
+46% +$698K
CMI icon
40
Cummins
CMI
$91.7B
$2.06M 0.56%
12,690
+880
+7% +$137K
PFE icon
41
Pfizer
PFE
$140B
$1.97M 0.54%
61,666
+11,287
+22% +$356K
CTSH icon
42
Cognizant
CTSH
$21.5B
$1.87M 0.51%
28,190
-2,772
-9% -$176K
HDB icon
43
HDFC Bank
HDB
$119B
$1.85M 0.51%
85,120
-25,000
-23% -$522K
QQQ icon
44
Invesco QQQ Trust
QQQ
$455B
$1.84M 0.5%
13,447
+8,907
+196% +$1.22M
KDP icon
45
Keurig Dr Pepper
KDP
$40.4B
$1.77M 0.49%
19,396
+1,800
+10% +$168K
YUM icon
46
Yum! Brands
YUM
$41B
$1.77M 0.48%
24,068
+1,798
+8% +$125K
MRK icon
47
Merck
MRK
$324B
$1.76M 0.48%
28,785
+2,872
+11% +$175K
RTX icon
48
RTX Corp
RTX
$287B
$1.75M 0.48%
23,217
+9,914
+75% +$743K
LEN icon
49
Lennar Class A
LEN
$20.4B
$1.73M 0.47%
34,115
-900
-3% -$44.3K
AMAT icon
50
Applied Materials
AMAT
$426B
$1.72M 0.47%
41,900
+6,950
+20% +$295K
1
2
3 4 5

Similar funds

PJB
Paul John Balson Marina Del Rey, California $486M AUM 78.12% 1-Year Est. Return
IVA
International Value Advisers $615M AUM 6.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
PSSGI
P-STS SPV GP IA San Francisco, California $433M AUM
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
DK
Darrell & King Charlottesville, Virginia $633M AUM 49.4% 1-Year Est. Return
MCM
Matarin Capital Management New York $409M AUM 33.03% 1-Year Est. Return
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.